GNAS and KRAS Mutations Define Separate Progression Pathways in Intraductal Papillary Mucinous Neoplasm-Associated Carcinoma.
about
KRAS, GNAS, and RNF43 mutations in intraductal papillary mucinous neoplasm of the pancreas: a meta-analysisInsights into the Pathogenesis of Pancreatic Cystic Neoplasms.Diversity of Precursor Lesions For Pancreatic Cancer: The Genetics and Biology of Intraductal Papillary Mucinous NeoplasmNext-Generation Sequencing in Oncology: Genetic Diagnosis, Risk Prediction and Cancer Classification.Therapeutic Approach to Cystic Neoplasms of the Pancreas.Endoscopic ultrasound-guided fine-needle aspiration plus KRAS and GNAS mutation in malignant intraductal papillary mucinous neoplasm of the pancreas.Pancreatic intraductal tubulopapillary neoplasm is genetically distinct from intraductal papillary mucinous neoplasm and ductal adenocarcinoma.Intraductal papillary mucinous neoplasm of the pancreas - epidemiology, risk factors, diagnosis, and management.Pancreatic Cancer Chemoprevention Translational Workshop: Meeting ReportFundic gland differentiation of oncocytic/pancreatobiliary subtypes of pancreatic intraductal papillary mucinous neoplasm.The oncocytic subtype is genetically distinct from other pancreatic intraductal papillary mucinous neoplasm subtypes.Targeted DNA Sequencing Reveals Patterns of Local Progression in the Pancreatic Remnant Following Resection of Intraductal Papillary Mucinous Neoplasm (IPMN) of the Pancreas.Do molecular tests really differentiate malignant IPMNS from benign?Distinct pathways of pathogenesis of intraductal oncocytic papillary neoplasms and intraductal papillary mucinous neoplasms of the pancreas.Intraductal Papillary Mucinous Neoplasms of the Pancreas: Strategic Considerations.Integrated Genomic Characterization of Pancreatic Ductal Adenocarcinoma.Can we better predict the biologic behavior of incidental IPMN? A comprehensive analysis of molecular diagnostics and biomarkers in intraductal papillary mucinous neoplasms of the pancreas.GNAS mutations are present in colorectal traditional serrated adenomas, serrated tubulovillous adenomas and serrated adenocarcinomas with adverse prognostic features.Prognostic significance of E-cadherin and ZEB1 expression in intraductal papillary mucinous neoplasm.Simple Detection of Telomere Fusions in Pancreatic Cancer, Intraductal Papillary Mucinous Neoplasm, and Pancreatic Cyst Fluid.Intraductal Papillary Mucinous Neoplasm of the Pancreas in Young Patients: Tumor Biology, Clinical Features, and Survival Outcomes.Intraductal Papillary Mucinous Neoplasms of the Pancreas: Current Understanding and Future Directions for Stratification of Malignancy Risk.The curious case of Gαs gain-of-function in neoplasia.Pancreatic Cystic Lesions: Pathogenesis and Malignant Potential.Histo-molecular oncogenesis of pancreatic cancer: From precancerous lesions to invasive ductal adenocarcinoma
P2860
Q26741895-79241468-1154-47F3-96EA-BC62B02BECE1Q30234478-0A45B48B-6261-4EF8-8A8B-AAF2C281B189Q33635144-E0D1E68B-67AC-450A-B58A-602493A1583EQ34550417-E74590CA-EA51-4218-8192-D747FCFCC017Q37191275-C62E0ED9-3BE5-4AD9-A365-318FA0E272D1Q37509767-16BA5B79-6034-44FD-8642-ADCF247E7806Q38646960-3EB86FE9-4973-4F27-908B-E895A4BD0CA4Q38690531-3E5DFCD9-2CAF-4E3F-AD20-7E5AE0FF36F8Q38831886-33169191-776E-4D28-8237-E537EA639E4AQ39910034-019CDA13-598B-4101-84B3-A6489EA8EB95Q41105157-658DA226-FE01-436F-9F18-32896086D8CBQ42329894-FAB3C796-692E-4369-BFCF-560F9E740017Q42350987-4701D769-EFFC-4662-B4CF-6D24AE6BE482Q42721594-5C2055A2-01B3-4FAF-B656-BFF73D2B7C3AQ47561534-7D337089-34DB-485F-81BD-9A0032C8BBFEQ47950548-8FBF154F-9EE9-478D-84D0-7E86DF49A3EDQ48155929-D1AA42BC-7DF5-4B06-A07C-835EAC714A02Q48274593-18EA4BE2-50D1-4CBC-86D3-9B399BC0DDDDQ49178361-B990C29A-7A25-4027-B417-815913CC3612Q49923147-DFED8B1A-6B59-4C59-9ECD-16A9DBCECD5CQ50092131-84CDC995-BC87-4075-82BE-CBBF3C949781Q50101175-447FB675-31BA-4661-BE92-1E955EA65122Q54955004-BF3C0F46-D22F-4A9A-B4E6-73A039669F3EQ55410325-524CA02F-24F4-4A47-8AE3-833A6A486FB0Q58566683-1306EFD9-F651-41A4-A99B-26D431C65D0B
P2860
GNAS and KRAS Mutations Define Separate Progression Pathways in Intraductal Papillary Mucinous Neoplasm-Associated Carcinoma.
description
2015 nî lūn-bûn
@nan
2015 թուականի Փետրուարին հրատարակուած գիտական յօդուած
@hyw
2015 թվականի փետրվարին հրատարակված գիտական հոդված
@hy
2015年の論文
@ja
2015年論文
@yue
2015年論文
@zh-hant
2015年論文
@zh-hk
2015年論文
@zh-mo
2015年論文
@zh-tw
2015年论文
@wuu
name
GNAS and KRAS Mutations Define ...... Neoplasm-Associated Carcinoma.
@ast
GNAS and KRAS Mutations Define ...... Neoplasm-Associated Carcinoma.
@en
type
label
GNAS and KRAS Mutations Define ...... Neoplasm-Associated Carcinoma.
@ast
GNAS and KRAS Mutations Define ...... Neoplasm-Associated Carcinoma.
@en
prefLabel
GNAS and KRAS Mutations Define ...... Neoplasm-Associated Carcinoma.
@ast
GNAS and KRAS Mutations Define ...... Neoplasm-Associated Carcinoma.
@en
P2093
P2860
P1476
GNAS and KRAS Mutations Define ...... Neoplasm-Associated Carcinoma.
@en
P2093
A Rose Brannon
David Klimstra
Jennifer LaFemina
Marcus C Tan
Michael F Berger
Nancy Bouvier
Peter J Allen
Sasinya N Scott
William R Jarnagin
P2860
P304
845-854.e1
P356
10.1016/J.JAMCOLLSURG.2014.11.029
P577
2015-02-11T00:00:00Z